Managing Frequent Hypoglycemia and Hyperglycemia in Hospitalized Patients
Switch from basal-bolus to a basal-plus insulin regimen immediately, reduce total daily insulin dose by 20% if the patient was on ≥0.6 U/kg/day at home, and implement a real-time continuous glucose monitoring system with electronic health record alerts to prevent recurrent hypoglycemia while maintaining glucose targets of 140-180 mg/dL. 1, 2
Immediate Insulin Regimen Adjustment
The core problem here is iatrogenic hypoglycemia from overly aggressive insulin therapy. The basal-bolus approach, while effective for hyperglycemia control, carries a 4-6 times higher risk of hypoglycemia compared to sliding scale insulin and has a 12-30% incidence of mild hypoglycemia in controlled settings 1. For patients experiencing frequent hypoglycemia with concurrent hyperglycemia, transition to a basal-plus regimen, which consists of:
- Single daily basal insulin dose: 0.1-0.25 U/kg/day (lower end for high-risk patients)
- Correctional rapid-acting insulin only before meals or every 6 hours if NPO
- No scheduled prandial insulin until glycemic stability is achieved 1
This approach significantly reduces hypoglycemia risk while maintaining adequate glycemic control, particularly for patients with decreased oral intake or those undergoing procedures.
Dose Reduction Protocol
If your patient was on higher insulin doses at home (≥0.6 U/kg/day), reduce the total daily insulin dose by 20% during hospitalization to account for poor oral intake and increased hypoglycemia risk 1. Additional dose reductions are warranted for:
- Age >65 years
- Renal impairment
- Erratic or poor oral intake
- Recent hypoglycemic episodes
For insulin-naive patients or those on low doses, start conservatively at 0.3 U/kg/day total (not 0.5 U/kg) given the current instability 1.
Implement Continuous Glucose Monitoring
The Endocrine Society strongly recommends real-time CGM for inpatients at high risk for hypoglycemia 2. This is a strong recommendation specifically addressing your clinical scenario. CGM provides:
- Real-time glucose trend data to predict impending hypoglycemia
- Alerts for both hypoglycemia and hyperglycemia
- Reduced need for frequent fingersticks
- Better pattern recognition for insulin adjustment
The 2023 guideline specifically endorses CGM for select inpatient populations at high risk for hypoglycemia, which directly applies to your patient 2.
Leverage Electronic Health Record Systems
Implement an inpatient glycemic management program with EHR-based alerts - this is another strong recommendation from the Endocrine Society 2. Recent quality improvement data from 2025 shows that systematic approaches with real-time alerts significantly reduce hypoglycemia 3, 4. Key components include:
- Automated alerts when glucose <70 mg/dL
- Nursing protocols for immediate hypoglycemia treatment
- Automatic notification to prescribers for insulin dose adjustment
- Standardized point-of-care testing protocols 4
Adjust Correctional Insulin Threshold
Raise the correction insulin threshold from 150 mg/dL to 180 mg/dL 3. A 2025 quality improvement study demonstrated that increasing this threshold significantly reduced hypoglycemia associated with correction insulin (P < .001) 3. While this may result in slightly more hyperglycemia, the trade-off is acceptable given that hypoglycemia carries greater immediate morbidity and mortality risk than transient hyperglycemia in the 180-200 mg/dL range.
Coordinate Meal Delivery and Insulin Timing
A critical but often overlooked cause of hypoglycemia is the mismatch between insulin administration and meal delivery. Standardize meal delivery times and ensure prandial insulin is given only after confirming meal arrival 4. If meals are delayed or refused:
- Hold the prandial insulin dose entirely
- Use only correctional insulin if glucose >180 mg/dL
- Consider carbohydrate-limited diet options to reduce glycemic variability 3
Avoid These Common Pitfalls
Never use sliding scale insulin alone in patients with established diabetes - this is explicitly condemned in guidelines and leads to persistent hyperglycemia 1. However, the opposite extreme of aggressive basal-bolus therapy is causing your current problem.
Do not use premixed insulin (70/30) in the hospital - it has an unacceptably high rate of iatrogenic hypoglycemia 1.
Do not continue home sulfonylureas or other secretagogues during hospitalization in unstable patients, as these contribute to unpredictable hypoglycemia 2.
Target Glucose Range
Maintain a target range of 140-180 mg/dL for most hospitalized patients 1, 5. Tighter control increases hypoglycemia risk without proven benefit in non-critically ill patients. Accept glucose values up to 200 mg/dL temporarily while stabilizing the regimen - preventing hypoglycemia takes priority over perfect glycemic control.
Structured Diabetes Education
The Endocrine Society strongly recommends structured diabetes education programs for patients at high risk for hypoglycemia 2. Before discharge, ensure the patient and nursing staff understand:
- Recognition of hypoglycemia symptoms
- Appropriate treatment (15-20g fast-acting carbohydrates)
- When to hold insulin doses
- Importance of meal timing
Monitoring Frequency
Increase point-of-care glucose monitoring to before each meal, at bedtime, and at 3 AM until the pattern stabilizes 4. The 3 AM check is essential to detect nocturnal hypoglycemia, which often goes unrecognized and contributes to the "brittle" pattern you're observing.